The identification of MPO gene mutations in patients with GPP further highlights the significance of MPO in psoriasis pathogenesis, offering potential avenues for targeted therapeutic interventions to mitigate inflammation and oxidative damage. This evidence concerns the gene MPO and psoriasis.